Larenks Kanseri
Özet
Larenks kanseri tedavisinden sonra hasta takipleri, nüks riskini azaltmak, sekonder malignitelerin erken tanısını sağlamak, tedavi sonrası gelişebilecek komplikasyonları yönetmek ve yaşam kalitesini artırmak açısından kritik öneme sahiptir. Takip sürecinde hastalara nüks belirtileri hakkında bilgilendirme yapılmalı, sigara ve alkol kullanımının bırakılması gibi yaşam tarzı değişiklikleri teşvik edilmelidir.Hastalığın evresine, uygulanan tedavi yöntemine ve genel sağlık durumuna göre takip protokolleri belirlenmelidir. Fiziksel muayene, kan tetkikleri, radyolojik görüntüleme ve gerektiğinde endoskopik inceleme takip süreçlerine dahil edilmelidir. Asemptomatik hastalar için rutin görüntüleme konusunda kesin bir fikir birliği bulunmasa da lokalize erken evre hastalıkta yakın takip protokollerinin daha etkin olduğu gösterilmiştir. Total larenjektomi sonrası konuşma ve yutma rehabilitasyonu, hastaların yaşam kalitesini artırmada önemlidir. Radyoterapi sonrası hipotiroidi ve hipopitüitarizm gibi endokrin fonksiyon bozukluklarının izlenmesi gereklidir. Takiplerde, nükslerin yanı sıra, beslenme sorunları, kronik semptomlar ve psikososyal desteğin sağlanması gibi konular da dikkate alınmalıdır. Sonuç olarak, larenks kanseri tedavisi sonrası multidisipliner bir yaklaşım benimsenmelidir. Tıbbi takiplerle birlikte hastaların psikososyal ve duygusal destek alması sağlanmalı, yaşam kalitesini optimize etmek temel hedeflerden biri olmalıdır.
Follow-up care after laryngeal cancer treatment is critically important for reducing the risk of recurrence, facilitating the early detection of secondary malignancies, managing post-treatment complications, and improving patients' quality of life. Patients should be educated about the signs and symptoms of recurrence, and lifestyle modifications such as smoking cessation and alcohol avoidance should be strongly encouraged.Follow-up protocols should be tailored based on the stage of the disease, treatment modality, and the patient’s overall health status. These protocols should include physical examinations, laboratory tests, radiological imaging, and endoscopic evaluations when necessary. While there is no consensus on routine imaging for asymptomatic patients, close follow-up has been shown to be more effective in localized early-stage disease. Rehabilitation of speech and swallowing after total laryngectomy plays a vital role in enhancing patients' quality of life. Monitoring for endocrine dysfunctions such as hypothyroidism and hypopituitarism, which are common after radiotherapy, is essential. In addition to monitoring for recurrence, follow-up care should address nutritional issues, chronic symptoms, and the provision of psychosocial support. In conclusion, a multidisciplinary approach is essential in the follow-up care of laryngeal cancer patients. Alongside medical monitoring, providing psychosocial and emotional support is crucial to optimizing patients' quality of life, which should remain a primary objective of post-treatment care.
Referanslar
Miller SJ. The National Comprehensive Cancer Network (NCCN) guidelines of care for nonmelanoma skin cancers. Dermatol Surg. 2000;26(3):289-292. Accessed December 15, 2024. https://journals.lww.com/dermatologicsurgery/citation/2000/03000/The_National_Comprehensive_Cancer_Network__NCCN_.27.aspx
Kamiya K, Ozasa K, Akiba S, et al. Long-term effects of radiation exposure on health. The lancet. 2015;386(9992):469-478. Accessed December 15, 2024. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)61167-9/fulltext?rss%3Dyes=
Ljumanovic R, Langendijk JA, Hoekstra OS, Knol DL, Leemans CR, Castelijns JA. Pre- and post-radiotherapy MRI results as a predictive model for response in laryngeal carcinoma. Eur Radiol. 2008;18(10):2231-2240. doi:10.1007/s00330-008-0986-x
Ritoe SC, De Vegt F, Scheike IM, et al. Effect of routine follow‐up after treatment for laryngeal cancer on life expectancy and mortality: Results of a Markov model analysis. Cancer. 2007;109(2):239-247. doi:10.1002/cncr.22401
de Visscher AV, Manni JJ. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity: does it make sense? Arch Otolaryngol Neck Surg. 1994;120(9):934-939. Accessed December 16, 2024. https://jamanetwork.com/journals/jamaotolaryngology/article-abstract/622424
Francis DO, Yueh B, Weymuller EA, Merati AL. Impact of surveillance on survival after laryngeal cancer in the medicare population. The Laryngoscope. 2009;119(12):2337-2344. doi:10.1002/lary.20576
Hall SF, Owen T, Griffiths RJ, Brennan K. Does the frequency of routine follow-up after curative treatment for head-and-neck cancer affect survival? Curr Oncol Tor Ont. 2019;26(5):295-306. doi:10.3747/co.26.4949
Boysen M, Lövdal O, Tausjö J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer Oxf Engl 1990. 1992;28(2-3):426-430. doi:10.1016/s0959-8049(05)80068-1
Barker LM, Pendergrass TW, Sanders JE, Hawkins DS. Survival After Recurrence of Ewing’s Sarcoma Family of Tumors. J Clin Oncol. 2005;23(19):4354-4362. doi:10.1200/JCO.2005.05.105
Agrawal A, Hammond TH, Young GS, Avon AL, Ozer E, Schuller DE. Factors affecting long-term survival in patients with recurrent head and neck cancer may help define the role of post-treatment surveillance. The Laryngoscope. 2009;119(11):2135-2140. doi:10.1002/lary.20527
Haas I, Hauser U, Ganzer U. The dilemma of follow-up in head and neck cancer patients. Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino-Laryngol - Head Neck Surg. 2001;258(4):177-183. doi:10.1007/s004050100333
Roland NJ, Bradley PJ. The role of surgery in the palliation of head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2014;22(2):101-108. doi:10.1097/MOO.0000000000000031
Posttreatment surveillance of squamous cell carcinoma of the head and neck - UpToDate. Accessed December 16, 2024. https://www.uptodate.com/contents/posttreatment-surveillance-of-squamous-cell-carcinoma-of-the-head-and-neck?search=Posttreatment%20surveillance%20of%20squamous%20cell%20carcinoma%20of%20the%20head%20and%20neck&source=search_result&selectedTitle=1%7E150&usage_type=default&display_rank=1
head-and-neck.pdf. Accessed December 16, 2024. https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf
Chen AM, Garcia J, Granchi PJ, Johnson J, Eisele DW. Late recurrence from salivary gland cancer: when does “cure” mean cure? Cancer. 2008;112(2):340-344. doi:10.1002/cncr.23165
Spector JG, Sessions DG, Haughey BH, et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. The Laryngoscope. 2001;111(6):1079-1087. doi:10.1097/00005537-200106000-00028
Eichler M, Keszte J, Meyer A, et al. Tobacco and alcohol consumption after total laryngectomy and survival: A German multicenter prospective cohort study. Head Neck. 2016;38(9):1324-1329. doi:10.1002/hed.24436
Fortin A, Wang CS, Vigneault E. Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2009;74(4):1062-1069. doi:10.1016/j.ijrobp.2008.09.021
Caudell JJ, Gillison ML, Maghami E, et al. NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022. J Natl Compr Cancer Netw JNCCN. 2022;20(3):224-234. doi:10.6004/jnccn.2022.0016
Heineman TE, Kuan EC, St. John MA. When should surveillance imaging be performed after treatment for head and neck cancer? The Laryngoscope. 2017;127(3):533-534. doi:10.1002/lary.26268
Dunsky KA, Wehrmann DJ, Osman MM, Thornberry BM, Varvares MA. PET‐CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient. The Laryngoscope. 2013;123(9):2161-2164. doi:10.1002/lary.23941
Ho AS, Tsao GJ, Chen FW, et al. Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence. Cancer. 2013;119(7):1349-1356. doi:10.1002/cncr.27892
Eigentler TK, Mühlenbein C, Follmann M, Schadendorf D, Garbe C. S3-Leitlinie Diagnostik, Therapie und Nachsorge des Melanoms - Update 2015/2016, Kurzversion 2.0. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2017;15(6):e1-e41. doi:10.1111/ddg.13247
Mendenhall WM, Morris CG, Stringer SP, et al. Voice rehabilitation after total laryngectomy and postoperative radiation therapy. J Clin Oncol Off J Am Soc Clin Oncol. 2002;20(10):2500-2505. doi:10.1200/JCO.2002.07.047
Culton GL, Gerwin JM. Current trends in laryngectomy rehabilitation: a survey of speech-language pathologists. Otolaryngol--Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg. 1998;118(4):458-463. doi:10.1177/019459989811800405
Functional outcomes following treatment for advanced laryngeal cancer. Part I--Voice preservation in advanced laryngeal cancer. Part II--Laryngectomy rehabilitation: the state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group - PubMed. Accessed December 16, 2024. https://pubmed.ncbi.nlm.nih.gov/9597955/
Singer S, Wollbrück D, Dietz A, et al. Speech rehabilitation during the first year after total laryngectomy. Head Neck. 2013;35(11):1583-1590. doi:10.1002/hed.23183
